These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 22126897

  • 1. Post-antibiotic effect of colistin, alone and in combination with amikacin, on Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.
    Bozkurt-Güzel C, Gerçeker AA.
    J Antibiot (Tokyo); 2012 Feb; 65(2):83-6. PubMed ID: 22126897
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
    Lapointe JR, Bourget C, Mainville S, Lafleur L, Lagacé J, Montplaisir S.
    J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
    [No Abstract] [Full Text] [Related]

  • 4. [Bacteriological monitoring of the treatment of Pseudomonas aeruginosa infections with amikacin administrated at once-daily dosis in patients with cystic fibrosis].
    Canis F, Husson MO, Vic P, Ategbo S, Turck D, Courcol R, Leclerc H.
    Pathol Biol (Paris); 1995 Apr; 43(4):343-51. PubMed ID: 7567127
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [In vitro bactericidal activity of tobramycin and amikacin alone or in combination against Pseudomonas aeruginosa isolated from patients with cystic fibrosis].
    Bertrou A, Marty N, Henry S, Agueda L, Chabanon G.
    Pathol Biol (Paris); 1990 May; 38(5):366-75. PubMed ID: 2114606
    [Abstract] [Full Text] [Related]

  • 7. In vitro pharmacodynamic properties of colistin methanesulfonate and amikacin against Pseudomonas aeruginosa.
    Bozkurt-Guzel C, Gerceker AA.
    Indian J Med Microbiol; 2012 May; 30(1):34-8. PubMed ID: 22361758
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro efficacy of various antibiotic combinations against Pseudomonas aeruginosa isolates.
    Nazli E, Zer Y, Eksi F.
    J Int Med Res; 2015 Apr; 43(2):217-25. PubMed ID: 25547417
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Expression of the MexXY efflux pump in amikacin-resistant isolates of Pseudomonas aeruginosa.
    Islam S, Jalal S, Wretlind B.
    Clin Microbiol Infect; 2004 Oct; 10(10):877-83. PubMed ID: 15373880
    [Abstract] [Full Text] [Related]

  • 13. Consequences of combining cystic fibrosis- and non-cystic fibrosis-derived Pseudomonas aeruginosa antibiotic susceptibility results in hospital antibiograms.
    Bosso JA, Mauldin PD, Steed LL.
    Ann Pharmacother; 2006 Nov; 40(11):1946-9. PubMed ID: 17018687
    [Abstract] [Full Text] [Related]

  • 14. Antibiotic susceptabilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions.
    Hill D, Rose B, Pajkos A, Robinson M, Bye P, Bell S, Elkins M, Thompson B, Macleod C, Aaron SD, Harbour C.
    J Clin Microbiol; 2005 Oct; 43(10):5085-90. PubMed ID: 16207967
    [Abstract] [Full Text] [Related]

  • 15. In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method.
    He W, Kaniga K, Lynch AS, Flamm RK, Davies TA.
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):417-9. PubMed ID: 22995366
    [Abstract] [Full Text] [Related]

  • 16. Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009.
    Hawser SP.
    Int J Antimicrob Agents; 2011 Jun; 37(6):587. PubMed ID: 21493045
    [No Abstract] [Full Text] [Related]

  • 17. Activity of doripenem with and without levofloxacin, amikacin, and colistin against Pseudomonas aeruginosa and Acinetobacter baumannii.
    Pankuch GA, Seifert H, Appelbaum PC.
    Diagn Microbiol Infect Dis; 2010 Jun; 67(2):191-7. PubMed ID: 20338710
    [Abstract] [Full Text] [Related]

  • 18. Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up.
    Colin AA, Ali-Dinar T.
    Pediatr Pulmonol; 2010 Jun; 45(6):626-7. PubMed ID: 20503290
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pulmonary exacerbations in cystic fibrosis: it's time to be explicit!
    Marshall BC.
    Am J Respir Crit Care Med; 2004 Apr 01; 169(7):781-2. PubMed ID: 15044219
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.